-+ 0.00%
-+ 0.00%
-+ 0.00%

ULTRAGENYX PHARMACEUTICAL INC - PHASE 1/2 STUDY OF UX016 EXPECTED TO BEGIN IN H2 2026

Reuters·03/30/2026 12:30:00

Please log in to view news